Showing results (31-40 of 640) with videos related to
Sort By:
Pageof 64
Hypertension (Dallas, Tex. : 1979)|November 20, 1998
Effects of acute ACE inhibition on pulsatile renin and aldosterone secretion and their synchronyD Fliser, J D Veldhuis, R Dikow, et al.Kidney International|April 1, 1997
Renal function in the elderly: impact of hypertension and cardiac functionD Fliser, E Franek, M Joest, et al.American Journal of Hypertension|April 1, 1993
Serum lipid changes on low salt diet. Effects of alpha 1-adrenergic blockadeD Fliser, R Nowack, N Allendorf-Ostwald, et al.European Journal of Clinical Pharmacology|June 24, 1999
Renal handling of drugs in the healthy elderly. Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchangedD Fliser, I Bischoff, A Hanses, et al.Journal of Hypertension|March 1, 1997
Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onsetD Fliser, C Keller, P Bahrmann, et al.Kidney International|February 13, 1999
Coadministration of albumin and furosemide in patients with the nephrotic syndromeD Fliser, I Zurbrüggen, E Mutschler, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 1997
Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humansD Fliser, E Franek, P Fode, et al.Kidney International|May 9, 1998
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal diseaseD Fliser, G Pacini, R Engelleiter, et al.European Journal of Clinical Pharmacology|January 1, 1994
Pharmacokinetics and pharmacodynamics of lisinopril in advanced renal failure. Consequence of dose adjustmentM Neubeck, D Fliser, M Pritsch, et al.European Journal of Clinical Investigation|January 26, 2005
Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk moleculeD FliserPageof 64